REFERENCES

1. Asia population 2024. Available from: https://worldpopulationreview.com/continents/asia-population [Last accessed on 28 Feb 2024].

2. News & insights. Rare disease care across Asia Pacific. 2023. Available from: https://sandpipercomms.com/health/rare-disease-care-across-asia-pacific/ [Last accessed on 28 Feb 2024].

3. Jain R. Rare diseases in Asia and the Pacific must be tackled too. Asia Pathways. 2020. Available from: https://www.asiapathways-adbi.org/2020/07/rare-diseases-asia-pacific-must-be-tackled-too/ [Last accessed on 28 Feb 2024].

4. The Economist Intelligence Unit. Suffering in silence: assessing rare disease awareness and management in Asia-Pacific. 2020. Available from: https://www.cslbehring.com.au/-/media/shared/economist-white-paper/eng_white-paper_a4_digital_final.pdf [Last accessed on 28 Feb 2024].

5. Shafie AA, Supian A, Hassali MAA, et al. Correction: rare disease in Malaysia: challenges and solutions. PLoS One 2022;17:e0273939.

6. Chung CCY, Hong Kong Genome Project. Chu ATW; Chung BHY. Rare disease emerging as a global public health priority. Front Public Health 2022;10:1028545.

7. Shafie AA, Chaiyakunapruk N, Supian A, Lim J, Zafra M, Hassali MAA. State of rare disease management in Southeast Asia. Orphanet J Rare Dis 2016;11:107.

8. Wong-Rieger D, Claxton W, Vines R, Padilla C, Tsang KP, Hickinbotham L. An Asia pacific alliance for rare diseases. Patient 2015;8:11-7.

9. Dharssi S, Wong-Rieger D, Harold M, Terry S. Review of 11 national policies for rare diseases in the context of key patient needs. Orphanet J Rare Dis 2017;12:63.

10. Khosla N, Valdez R. A compilation of national plans, policies and government actions for rare diseases in 23 countries. Intractable Rare Dis Res 2018;7:213-22.

11. Chan AYL, Chan VKY, Olsson S, et al. Access and unmet needs of orphan drugs in 194 countries and 6 areas: a global policy review with content analysis. Value Health 2020;23:1580-91.

12. Gammie T, Lu CY, Babar ZU. Access to orphan drugs: a comprehensive review of legislations, regulations and policies in 35 countries. PLoS One 2015;10:e0140002.

13. Manatū Hauora. Rare disorders strategy. Available from: https://www.health.govt.nz/our-work/diseases-and-conditions/rare-disorders-strategy [Last accessed on 28 Feb 2024].

14. UNFPA. Population trends. Available from: https://asiapacific.unfpa.org/en/populationtrends#:~:text=The%20Asia%20and%20the%20Pacific,populous%20countries%2C%20China%20and%20India [Last accessed on 29 Feb 2024].

15. Statista. Total population in the Asia-Pacific region in 2022, by country or territory. Available from: https://www.statista.com/statistics/632565/asia-pacific-total-population-by-country/ [Last accessed on 28 Feb 2024].

16. Ministry of Health and Family Welfare. Steps taken for treatment of patients suffering from rare diseases. 2023. Available from: https://pib.gov.in/PressReleasePage.aspx?PRID=1942712 [Last accessed on 28 Feb 2024].

17. Digital portal for crowdfunding & voluntary donations for patients of rare diseases. Available from: https://rarediseases.mohfw.gov.in/Hospital_Treating_Rare_Diseases [Last accessed on 28 Feb 2024].

18. Ministry of Chemicals and Fertilizers. Dr Mansukh Mandaviya launches national policy on research and development and innovation in pharma-MedTech sector in India and Scheme for promotion of research and innovation in pharma MedTech sector (PRIP). Available from: https://pib.gov.in/PressReleasePage.aspx?PRID=1960812 [Last accessed on 28 Feb 2024].

19. First Chinese catalog of rare diseases. 2018. Available from: https://www.gov.cn/zhengce/zhengceku/2018-12/31/content_5435167.htm [Last accessed on 28 Feb 2024].

20. Second Chinese catalog of rare diseases. 2023. Available from: https://www.gov.cn/zhengce/zhengceku/202309/content_6905273.htm [Last accessed on 28 Feb 2024].

21. CHARD. 2023. Available from: https://www.chard.org.cn/detail/news/1941 [Last accessed on 28 Feb 2024].

22. Available from: https://www.gov.cn/zhengce/zhengceku/2019-10/08/content_5436962.htm [Last accessed on 28 Feb 2024].

23. Guo J, Liu P, Chen L, et al. Administrative group of national rare diseases registry system of China. National rare diseases registry system (NRDRS): China’s first nation-wide rare diseases demographic analyses. Orphanet J Rare Dis 2021;16:515.

24. Yayasan MPS & Penyakit Langka. Official opening of indonesia center of excellence for rare diseases. 2017. Available from: https://www.penyakitlangkaindonesia.org/events/official-opening-indonesia-center-excellence-rare-diseases [Last accessed on 28 Feb 2024].

25. Act on medical care for patients with intractable diseases. 1993. Available from: https://www.japaneselawtranslation.go.jp/ja/laws/view/3363 [Last accessed on 28 Feb 2024].

26. Act on securing quality, efficacy and safety of products including pharmaceuticals and medical devices. 1960. Available from: https://www.japaneselawtranslation.go.jp/ja/laws/view/3213 [Last accessed on 28 Feb 2024].

27. Republic act No. 10747. An act promulgating a comprehensive policy in addressing the needs of persons with rare disease. 2016. Available from: https://www.officialgazette.gov.ph/2016/03/03/republic-act-no-10747/ [Last accessed on 28 Feb 2024].

28. Manalansan A. Rare diseases: patients should not be left behind. BusinessWorld. 2022. Available from: https://www.bworldonline.com/opinion/2022/02/01/427221/rare-diseases-patients-should-not-be-left-behind/ [Last accessed on 28 Feb 2024].

29. Republic act no. 9288. An act promulgating a comprehensive policy and a national system for ensuring newborn screening. 2004. Available from: https://lawphil.net/statutes/repacts/ra2004/ra_9288_2004.html [Last accessed on 28 Feb 2024].

30. Law No. 105/2016/QH13. 2016. Available from: https://vss.gov.vn/english/legal/pages/default.aspx?ItemID=3550 [Last accessed on 28 Feb 2024].

31. Nature Portfolio. Fast-tracking rare disease diagnosis and treatment. Available from: https://www.nature.com/articles/d42473-020-00209-6 [Last accessed on 28 Feb 2024].

32. Sciascia S, Roccatello D, Salvatore M, et al. Unmet needs in countries participating in the undiagnosed diseases network international: an international survey considering national health care and economic indicators. Front Public Health 2023;11:1248260.

33. Kim MJ, Kim B, Lee H, et al. The Korean genetic diagnosis program for rare disease phase II: outcomes of a 6-year national project. Eur J Hum Genet 2023;31:1147-53.

34. Pharmaceutical affairs act. Available from: https://elaw.klri.re.kr/eng_mobile/viewer.do?hseq=57508&type=sogan&key=10 [Last accessed on 28 Feb 2024].

35. Ministry of Food and Drug Safety Notice. Regulation on designation of orphan drugs. 2018. Available from: https://www.mfds.go.kr/eng/brd/m_18/view.do?seq=71453 [Last accessed on 28 Feb 2024].

36. Kang D, Choi SE. Horizontal healthcare utilization inequity in patients with rare diseases in Korea. Int J Equity Health 2023;22:93.

37. Appendix 13: designation and registration of orphan medicines. Available from: https://www.npra.gov.my/easyarticles/images/users/1153/drgd_appendices/APPENDIX-13-Designation-and-Registration-of-Orphan-Medicines.pdf [Last accessed on 28 Feb 2024].

38. Shafie AA, Supian A, Ahmad Hassali MA, et al. Rare disease in Malaysia: challenges and solutions. PLoS One 2020;15:e0230850.

39. Parajuli N, Baskota R, Jain R. Genodermatoses picture: difficulties faced and way forward in Nepal. J Nepal Health Res Counc 2023;20:1008-12.

40. Pandey AS. Case reports of metabolic disorders from Nepal. Mol Genet Metab Rep 2019;21:100542.

41. Australian Government Department of Health and Aged Care. National strategic action plan for rare diseases. 2020. Available from: https://www.health.gov.au/resources/publications/national-strategic-action-plan-for-rare-diseases?language=en [Last accessed on 28 Feb 2024].

42. Rare Voices Australia. Implementing the national strategic action plan for rare diseases. May 2023 status report. 2023. Available from: https://rarevoices.org.au/wp-content/uploads/2023/05/Implementing-the-National-Strategic-Action-Plan-for-Rare-Diseases_May-2023-Status-Report.pdf [Last accessed on 28 Feb 2024].

43. Department of Health and Aged Care. Pharmaceutical benefits scheme (PBS).

44. Australian Government Department of Health and Aged Care. About the life saving drugs program. 2023. Available from: https://www.health.gov.au/our-work/life-saving-drugs-program/about-the-lsdp [Last accessed on 28 Feb 2024].

45. Government response. The new frontier: inquiry into approval processes for new drugs and novel medical technologies in Australia. 2023. Available from: https://www.aph.gov.au/Parliamentary_Business/Committees/House/Health_Aged_Care_and_Sport/Newdrugs/Government_Response [Last accessed on 28 Feb 2024].

46. Ministry of Health and Welfare. The Rare disease and orphan drug act. 2015. Available from: https://law.moj.gov.tw/ENG/LawClass/LawAll.aspx?pcode=L0030003 [Last accessed on 28 Feb 2024].

47. Hsiang NC, Huang WF, Gau CS, Tsai TW, Chang LC. The impact of the rare disease and orphan drug act in Taiwan. J Food Drug Anal 2021;29:717-25.

48. Adachi T, El-Hattab AW, Jain R, et al. Enhancing equitable access to rare disease diagnosis and treatment around the world: a review of evidence, policies, and challenges. Int J Environ Res Public Health 2023;20:4732.

49. LCQ20: policies and measures on rare diseases. Available from: https://www.info.gov.hk/gia/general/202105/05/P2021050500461.htm [Last accessed on 28 Feb 2024].

50. Chung CCY, Ng NYT, Ng YNC, et al. Socio-economic costs of rare diseases and the risk of financial hardship: a cross-sectional study. Lancet Reg Health West Pac 2023;34:100711.

51. Orphan Drugs & Rare Diseases. Drew & Napier/Singapore. Available from: https://pharmaboardroom.com/legal-articles/orphan-drugs-rare-diseases-singapore/ [Last accessed on 28 Feb 2024].

52. Minister for Health. Singaporeans diagnosed with rare diseases and coverage by rare disease fund. 2023. Available from: https://www.moh.gov.sg/news-highlights/details/singaporeans-diagnosed-with-rare-diseases-and-coverage-by-rare-disease-fund [Last accessed on 28 Feb 2024].

53. Rare Disease Fund. What is the rare disease fund? Available from: https://www.kkh.com.sg/giving/Documents/Rare-Disease-Fund/index.html [Last accessed on 28 Feb 2024].

54. Agency for Care Effectiveness. Drug and vaccine evaluation methods and process guide. 2023. Available from: https://www.ace-hta.gov.sg/docs/default-source/process-methods/drug-and-vaccine-evaluation-methods-and-process-guide-version-3-1-(september-2023).pdf [Last accessed on 28 Feb 2024].

55. Pae Ora (healthy futures) bill. Government bill 85-3. 2021. Available from: https://legislation.govt.nz/bill/government/2021/0085/latest/whole.html#LMS575405 [Last accessed on 28 Feb 2024].

56. Priority lists for funding applications. Available from: https://pharmac.govt.nz/medicine-funding-and-supply/the-funding-process/priority-lists [Last accessed on 28 Feb 2024].

57. Funding for rare disorders. Available from: https://pharmac.govt.nz/medicine-funding-and-supply/the-funding-process/from-application-to-funded-medicine-how-we-fund-a-medicine/medicines-for-rare-disorders [Last accessed on 28 Feb 2024].

58. The Pharmac Review. Available from: https://pharmac.govt.nz/about/pharmacreview [Last accessed on 28 Feb 2024].

59. New Zealand Health Strategy. 2023. Available from: https://www.health.govt.nz/publication/new-zealand-health-strategy [Last accessed on 28 Feb 2024].

60. Provisional Health of Disabled People Strategy. 2023. Available from: https://www.health.govt.nz/publication/provisional-health-disabled-people-strategy [Last accessed on 28 Feb 2024].

61. Rare Disorders New Zealand. Rare support centre aotearoa. 2023. Available from: https://www.raredisorders.org.nz/assets/Documents/RSCA-centre-of-expertise-131123-v2.pdf [Last accessed on 28 Feb 2024].

62. Chung CCY, Ng YNC, Jain R, Chung BHY. A thematic study: impact of COVID-19 pandemic on rare disease organisations and patients across ten jurisdictions in the Asia Pacific region. Orphanet J Rare Dis 2021;16:119.

63. Chung CC, Wong WH, Fung JL, Hong Kong RD, Chung BH. Impact of COVID-19 pandemic on patients with rare disease in Hong Kong. Eur J Med Genet 2020;63:104062.

64. Padilla CD, Therrell BL Jr, Alcausin MMLB, et al. Successful implementation of expanded newborn screening in the Philippines using tandem mass spectrometry. Int J Neonatal Screen 2022;8:8.

65. Political declaration of the high-level meeting on universal health coverage. Universal health coverage: moving together to build a healthier world. Available from: https://www.un.org/pga/73/wp-content/uploads/sites/53/2019/07/FINAL-draft-UHC-Political-Declaration.pdf [Last accessed on 28 Feb 2024].

66. UN. General Assembly (76th sess.: 2021-2022). Addressing the challenges of persons living with a rare disease and their families: resolution/adopted by the general assembly. 2021. Available from: https://digitallibrary.un.org/record/3953765?ln+=+en&ln=ar [Last accessed on 28 Feb 2024].